Feasibility of Digital Thermal Monitoring to Assess Endothelium-Dependent Vasodilation in Patients Undergoing Hematopoietic Cell Transplantation (HCT)

Stopped early · Not applicable

Conditions studied: Vascular, Endothelial, Endothelial Dysfunction, Endothelix

In brief

The Vendys II, an FDA-approved device, uses finger digital thermal monitoring (DTM) after a period of blood flow restriction to evaluate vascular health. This study will evaluate the feasibility of using this device to measure the Vascular Reactivity Index (VRI) in children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT).

Key facts

Study ID

NCT05029752

Run by

M.D. Anderson Cancer Center

People needed

27

Starts

2021-06-30

Expected to finish

2025-08-29

Last updated by the study team

2026-07-15

Who can join

Age: 6 and older, up to 26. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Any subject who does not consent/assent to participation.
• . Any subject with an injury or deformation to the index finger which prevents proper fit of the device.
• Any subject with skin toxicity or neuropathy which prevents comfortable use of the device.

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.